UB Paderborn / Katalog / Suche / in CDI

Efficacy of small-volume simethicone given at least 30 min before gastroscopy

World journal of gastrointestinal pharmacology and therapeutics, 2016-11, Vol.7 (4), p.572-578

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites

Singapore medical journal, 2021-12, Vol.62 (12), p.659-664

2021

Link zum Volltext

Verfügbarkeit prüfen

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Clinical and Molecular Hepatology, 2019, 25(3), , pp.326-330

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore

Hepatobiliary & pancreatic diseases international, 2019-04, Vol.18 (2), p.143-148

2019

Link zum Volltext

Verfügbarkeit prüfen

VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

Clinical and Molecular Hepatology, 2019, 25(2), , pp.218-222

2019

Link zum Volltext

Verfügbarkeit prüfen

SAT327 - What is required for achieving HCV elimination in Singapore? A modeling study

Journal of hepatology, 2020-08, Vol.73, p.S818-S818

2020

Link zum Volltext

Verfügbarkeit prüfen

What is required for achieving HCV elimination in Singapore? A modeling study

Journal of hepatology, 2020-08, Vol.73, p.S818

2020

Link zum Volltext

Verfügbarkeit prüfen

557 VALIDATION STUDY: ALBI GRADE OUTPERFORMS CHILD-PUGH SCORE IN PREDICTING SURVIVAL AND DECOMPENSATION AMONG COMPENSATED CIRRHOSIS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1281-S-1282

2020

Link zum Volltext

Verfügbarkeit prüfen

What is required for achieving hepatitis C virus elimination in Singapore? A modeling study

Journal of gastroenterology and hepatology, 2021-04, Vol.36 (4), p.1110-1117

2021

Link zum Volltext

Verfügbarkeit prüfen

What is required for achieving HCV elimination in Singapore? A modeling study

Journal of gastroenterology and hepatology, 2020-09, Vol.36 (4), p.1110-1117

2020

Link zum Volltext

Verfügbarkeit prüfen

Is routine Ribavirin mandatory for genotype 3 hepatitis C compensated cirrhosis patients receiving Sofosbuvir/Velpatasvir? A meta-analysis

Journal of hepatology, 2022-07, Vol.77, p.S567

2022

Link zum Volltext

Verfügbarkeit prüfen

Tu1525 – Short-Term and Long-Term Outcome Predictor for Nosocomial Spontaneous Bacterial Peritonitis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1352-S-1353

2019

Link zum Volltext

Verfügbarkeit prüfen

Tu1726 RIFAXIMIN AS FIRST-LINE THERAPY FOR PRIMARY PROPHYLAXIS OF SPONTANEOUS BACTERIAL PERITONITIS AMONG DECOMPENSATED CIRRHOSIS: NETWORK META-ANALYSIS OF RANDOMISED TRIALS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-1471-S-1472

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sofosbuvir/velpatasvir in a real‐world chronic hepatitis C genotype 3 cohort

Journal of gastroenterology and hepatology, 2021-05, Vol.36 (5), p.1300-1308

2021

Link zum Volltext

Verfügbarkeit prüfen

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Clinical and molecular hepatology, 2019-09, Vol.25 (3), p.326-330

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis

World journal of hepatology, 2022-06, Vol.14 (6), p.1248-1257

2022

Link zum Volltext

Verfügbarkeit prüfen

Authors' reply: Comment on: Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites

Singapore medical journal, 2021-12, Vol.62 (12), p.666-666

2021

Link zum Volltext

Verfügbarkeit prüfen

The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

Journal of hepatology, 2020-08, Vol.73, p.S313

2020

Link zum Volltext

Verfügbarkeit prüfen

THU354 - The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

Journal of hepatology, 2020-08, Vol.73, p.S313-S313

2020

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study

Singapore medical journal, 2022-02, Vol.63 (2), p.86-92

2022

Link zum Volltext

Verfügbarkeit prüfen

Sa1404 The Learning Curve of Needle Knife Precut Revisited

Gastrointestinal endoscopy, 2017-05, Vol.85 (5), p.AB228-AB228

2017

Link zum Volltext

Verfügbarkeit prüfen

The difference in histological yield between 19G EUS-FNA and EUS-fine-needle biopsy needles

Endoscopic Ultrasound, 2019-07, Vol.8 (4), p.255-260

2019

Link zum Volltext

Verfügbarkeit prüfen

TC‐325 versus the conventional combined technique for endoscopic treatment of peptic ulcers with high‐risk bleeding stigmata: A randomized pilot study

Journal of digestive diseases, 2017-06, Vol.18 (6), p.323-329

2017

Link zum Volltext

Verfügbarkeit prüfen

The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients

Clinical and molecular hepatology, 2021-07, Vol.27 (3), p.474-485

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study

Clinics and research in hepatology and gastroenterology, 2021-11, Vol.45 (6), p.101598-101598, Article 101598

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Efficacy of small-volume simethicone given at least 30 min before gastroscopy

Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore

VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

SAT327 - What is required for achieving HCV elimination in Singapore? A modeling study

What is required for achieving HCV elimination in Singapore? A modeling study

557 VALIDATION STUDY: ALBI GRADE OUTPERFORMS CHILD-PUGH SCORE IN PREDICTING SURVIVAL AND DECOMPENSATION AMONG COMPENSATED CIRRHOSIS

What is required for achieving hepatitis C virus elimination in Singapore? A modeling study

What is required for achieving HCV elimination in Singapore? A modeling study

Is routine Ribavirin mandatory for genotype 3 hepatitis C compensated cirrhosis patients receiving Sofosbuvir/Velpatasvir? A meta-analysis

Tu1525 – Short-Term and Long-Term Outcome Predictor for Nosocomial Spontaneous Bacterial Peritonitis

Tu1726 RIFAXIMIN AS FIRST-LINE THERAPY FOR PRIMARY PROPHYLAXIS OF SPONTANEOUS BACTERIAL PERITONITIS AMONG DECOMPENSATED CIRRHOSIS: NETWORK META-ANALYSIS OF RANDOMISED TRIALS

Efficacy and safety of sofosbuvir/velpatasvir in a real‐world chronic hepatitis C genotype 3 cohort

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis

Authors' reply: Comment on: Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites

The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

THU354 - The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study

Sa1404 The Learning Curve of Needle Knife Precut Revisited

The difference in histological yield between 19G EUS-FNA and EUS-fine-needle biopsy needles

TC‐325 versus the conventional combined technique for endoscopic treatment of peptic ulcers with high‐risk bleeding stigmata: A randomized pilot study

The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients

Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study

Suchergebnisse filtern